Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: An analysis of geographic variability

British Journal of Cancer

Volumn 109, Issue 1, 2013, Pages 219-228

  Crocetti, E ^a   De Angelis, R ^b   Buzzoni, C ^a,c   Mariotto, A ^d   Storm, H ^e   Colonna, M ^f   Zanetti, R ^g   Serraino, D ^h   Michiara, M ⁱ   Cirilli, C ^j   Iannelli, A ^k   Mazzoleni, G ^l   Sechi, O ^m   Sanoja Gonzalez, M E ⁿ   Guzzinati, S ^o   Capocaccia, R ^b   Dal Maso, L ^p   Zucchetto, A ^q   Caldarella, A ^r   Bovo, E ^s   Tagliabue, G ^t   Vercelli, M ^u   Falcini, F ^v   Randi, G ^w   Petrucci, S ^x   Ferretti, S ^y   Pannozzo, F ^z   Mangone, L ^aa   Piffer, S ^ab   Fusco, M ^ac   Giacomin, A ^ad   Tisano, F ^ae   Zarcone, M ^af   more..

^a Istituto per Lo Studio e la Prevenzione Oncologica (ISPO Toscana)   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c AIRTUM Database   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

^e DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g MOLINETTE HOSPITAL   (Italy)

^h Friuli Venezia Giulia Cancer Registry   (Italy)

ⁱ UNIVERSITY HOSPITAL OF PARMA   (Italy)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k Salerno Cancer Registry   (Italy)

^l Alto Adige Sudtirol Cancer Registry   (Italy)

^m Cancer Registry of Sassari   (Italy)

ⁿ Local Health Unit   (Italy)

^o VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^p CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^q Epidemiology and Biostatistics Unit   (Italy)

^r Tuscany Cancer Registry   (Italy)

^s Registro tumori Veneto   (Italy)

^t Istituto Nazionale dei Tumori   (Italy)

^u Liguria Cancer Registry at IRCSS AOU SMartino IST UNIGE   (Italy)

^v Romagna Cancer Registry   (Italy)

^w Cancer Registry of Milan   (Italy)

^x Umbria Cancer Registry   (Italy)

^y Ferrara Cancer Registry   (Italy)

^z Latina Cancer Registry   (Italy)

^aa Reggio Emilia Cancer Registry   (Italy)

^ab Osservatorio Epidemiologico   (Italy)

^ac Napoli Cancer Registry   (Italy)

^ad Biella Cancer Registry   (Italy)

^ae Syracuse Province Registry   (Italy)

^af Palermo Breast Cancer Registry   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGING; ARTICLE; AUSTRALIA; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PREVALENCE; CANCER SURVIVAL; COLORECTAL CANCER; DENMARK; ESOPHAGUS CANCER; EUROPE; FAROE ISLANDS; FEMALE; FINLAND; FOLLOW UP; FRANCE; HODGKIN DISEASE; HUMAN; ICELAND; ITALY; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL GEOGRAPHY; MELANOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NORWAY; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; SWEDEN; THYROID CANCER; UNITED STATES; UTERINE CERVIX CANCER;

EID: 84880260069     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.311     Document Type: Article

References (42)

1. AIRTUM Working Group (2010) Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. Epidemiol Prev 34: 1-188.
2. AIHW (Australian Institute of Health and Welfare) (2010) Australian Cancer Incidence and Mortality Books. AIHW ACIM: Canberra.
3. AIHW (Australian Institute of Health and Welfare), Cancer Australia & Australasian Association of Cancer Registries (2008) Cancer Survival and Prevalence in Australia: Cancers Diagnosed from 1982 to 2004 Camberra.
4. AIHWCancer Series no. 42. Cat. no. CAN 38. http://www.aihw.gov.au/ publication-detail/?id=6442468141 (Accessed on 17 June 2013).
5. Barlow WE (2009) Overview of methods to estimate the medical costs of cancer. Med Care 47: S33-S36.
6. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M. EUROCARE Working group (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8: 773-783.
7. Bray F, Ren JS, Masuyer E, Ferlay J (2012) Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132(5): 1133-1145.
8. Canfell K, Banks E, Moa AM, Beral V (2008) Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 188: 641-644.
9. Capocaccia R, Colonna M, Corazziari I, De Angelis R, Francisci S, Micheli A, Mugno E. EUROPREVAL Working Group (2002) Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol 13: 831-839.
10. CBTRUS (2011) CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007.
11. Source: Central Brain Tumor Registry of the United States, Hinsdale IL. Available at: /www.cbtrus.org/2011-NPCR-SEER/WEB-0407-Report-3-3- 2011.pdf (Accessed on 17 June 2013).
12. Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59: 366-378.
13. Coleman M, Quaresima M, Berrino F, Lutz JM, De angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL. CONCORD Working Group (2008) Cancer Survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9: 730-756.
14. Colonna M, Danzon A, Delafosse P, Mitton N, Bara S, Bouvier AM, Ganry O, Guizard AV, Launoy G, Molinie F, Sauleau EA, Schvartz C, Velten M, Grosclaude P, Tretarre B (2008) Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. Eur J Cancer 44: 115-122.
15. Corazziari I, Quinn M, Capocaccia R (2004) Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40: 2307-2316.
16. Crocetti E, Buzzoni C, Falcini F, Cortesi L, De Lisi V, Ferretti S, Tumino R, Russo A, Paci E (2010) Disentangling the roles of mammographic screening and HRT in recent breast cancer incidence trends in Italy by analyses based on calendar time and time since screening activation. Breast J 16: 350-355.
17. Crocetti E, Buzzoni C, Quaglia A, Lillini R, Vercelli M. AIRTUM Working Group (2012) Ageing and other factors behind recent cancer incidence and mortality trends in Italy. J Geriatr Oncol 3: 111-119.
18. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (2007) Cancer Incidence in Five Continents. Vol. IX. IARC Sci. Publ. No. 160. IARC: Lyon.
19. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, Køtlum JE, Olafsdo'ttir E, Pukkala E, Storm HH (2010) NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 49: 725-736.
20. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781.
21. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. IARC: Lyon, available at: http://globocan.iarc.fr (Accessed on 17 June 2013).
22. Guzzinati S, Buzzoni C, De Angelis R, Rosso S, Tagliabue G, Vercelli M, Pannozzo F, Mangone L, Piffer S, Fusco M, Giacomin A, Traina A, Capocaccia R, Dal Maso L, Crocetti E. AIRTUM working group (2012) Cancer prevalence in Italy: an analysis of geographic variability. Cancer Causes Control 23: 1497-1510.
23. Hofvind S, Sakshaug S, Ursin G, Graff-Iversen S (2012) Breast cancer incidence trends in Norway-explained by hormone therapy or mammographic screening? Int J Cancer 130: 2930-2938.
24. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR et al. (eds) (2009) SEER Cancer Statistics Review, 1975-2006. NCI: Bethesda. http://seer.cancer.gov/csr/ 1975-2006/based on November 2008 SEER data submission, posted to the SEER website (Accessed on 17 June 2013).
25. IARC (2004) Tobacco Smoke and Involuntary Smoking. IARC Monogr Eval Carcinog Risks Hum 38. IARC: Lyon.
26. Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, Moller H (2009) Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer 101: 541-547.
27. Mariotto A, Yabroff RK, Feuer EJ, De Angelis R, Brown ML (2006) Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control 17: 1215-1226.
28. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML (2011) Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103: 117-128. Erratum in: J Natl Cancer Inst 2011 Apr 20;103(8):699.
29. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R. EUROPREVAL Working Group (2002) Cancer prevalence in European registry areas. Ann Oncol 13: 840-865.
30. Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, Neal C, Ulrich A, Travado L, Santini LA, Grassi L, De Lorenzo F, Costa A, Dangou JM, Bisanti L, Seniori Costantini A, Abu-Rmeileh N, Kamal M, Federico M, Saracci R, Rennert G, Stefanini A, Cavalli F, Cazap E, Redmond K, O'Reilly S, Muti P, Casali P, Gatta G, Ferrari A, Koifman S, Bah E, Pastore G, Barr R, Lombardo C, Frazzingaro C, Ciampichini R, Baili P. ICCC-3 Session B Group (2009) International collaborations in cancer control and the third international cancer control congress. Tumori 95: 579-596.
31. Patriarca S, Gafa L, Ferretti S, Vitarelli S, Cesaraccio R, Crocetti E, Ferrante M, Rollo P, Tagliabue G (2001) Coding criteria of bladder cancer: effects on estimating survival. Epidemiol Prev 25: 42-47.
32. Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97: 72-81.
33. Roehrborn CG, Black LK (2011) The economic burden of prostate cancer. BJU Int 108: 806-813.
34. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Pa'ez A, Ma?a?tta?nen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman U-H, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A. for the ERSPC Investigators (2012) Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 366: 981-990.
35. SEER (2012) SEER*Stat Database: Incidence-SEER 9 Registries Research Data, Sub (1973-2006) www.seer.cancer.gov.
36. Séradour B, Allemand H, Weill A, Ricordeau P (2009) Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 96: E16.
37. United Nations (2012) United Nations 2010 estimates. http://esa.un.org/ unpd/ wpp/Excel-Data/population.htm (Accessed on 17 June 2013).
38. Verdecchia A, Micheli A, Colonna M, Moreno V, Izarzugaza MI, Paci E. EUROPREVAL Working Group (2002) A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol 13: 1128-1139.
39. Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman P (2009) The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. Maturitas 64: 80-85.
40. WHO (1992) International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. World Health Organization: Geneva.
41. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. AICR: Washington DC.
42. Yabroff RK, Mariotto AB, Feuer EJ, Brown ML (2008) Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ 17: 947-959.